Kriya Therapeutics
Pre-clinicalKriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $180.5M
About
Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
RNA & Gene Therapy
Funding History
2Total raised:$180.5M
Series B$100MNov 15, 2021
Series A$80.5MAug 15, 2020